JenaValve prosthesis 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 JenaValve Technology 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2015-10-13
  • 사례 출판 날짜
    2015-10-13
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: jenavalve prosthesis the medicines and healthcare products regulatory agency (mhra), united kingdom posted a medical device safety alert concerning jenavalve prosthesis, manufactured by jenavalve technology. the manufacturer has received notice that during a routine implantation in an ar patient using a size 27 jenavalve prosthesis, significant paravalvular leakage (pvl) occurred despite adequate positioning and deployment of the prosthesis. as pvl did not resolve following repeat balloon valvuloplasty, a valve-in-valve procedure had to be performed. prior to the procedure, a standardized mdct scan and software-mediated three dimensional reconstructions were used to calculate the patient’s native annular size and choose the corresponding prosthesis. annular dimensions in diastolic phase of the cardiac cycle were used. during the manufacturer’s investigation, repeat assessment of the mdct data in both diastolic and systolic phase was performed. it has become apparent that during systolic assessment, the patient’s annular size was significantly larger if compared to diastolic assessment and, in this specific case, potentially lead to prosthesis undersizing and pvl. the manufacturer has recommended the following measures for this issue:- always use systolic mdct data (10-20% of the cardiac cycle) to assess the largest annular dimension prior to selecting the corresponding prosthesis size to avoid potential undersizing and associated paravalvular leakage. perform systolic assessment of annular dimensions in both as and ar patients, as also in calcified as, systolic annular dimensions are larger in systole if compared to diastole, thus impacting prosthesis size selection. for details, please refer to the mhra website:https://www.Gov.Uk/government/publications/safety-information-from-manufacturers-field-safety-notices/field-safety-notices-5-to-9-october-2015 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 13 october 2015.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: JenaValve prosthesis
  • Manufacturer

Manufacturer